CAR T-Cell Therapy in Large B-Cell Lymphoma

被引：45

作者：

Quintas-Cardama, Alfonso ^{[1
]}

机构：

[1] TCR2 Therapeut, Cambridge, MA 02142 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 11期

关键词：

TRIAL;

D O I：

10.1056/NEJMc1800913

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1065 / 1065

页数：1

共 5 条

[1]

Ahmed MA, 2015, HEMATOL ONCOL S1, V33, P375

[2] Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections [J].

Casulo, Carla ;

Maragulia, Jocelyn ;

Zelenetz, Andrew D. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02) :106-111

[3] Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study [J].

Crump, Michael ;

Neelapu, Sattva S. ;

Farooq, Umar ;

Van den Neste, Eric ;

Kuruvilla, John ;

Westin, Jason ;

Link, Brian K. ;

Hay, Annette ;

Cerhan, James R. ;

Zhu, Liting ;

Boussetta, Sami ;

Feng, Lei ;

Maurer, Matthew J. ;

Navale, Lynn ;

Wiezorek, Jeff ;

Go, William Y. ;

Gisselbrecht, Christian .

BLOOD, 2017, 130 (16) :1800-1808

[4]

Neelapu SS, 2017, BLOOD, V130

[5] PHASE-II TRIAL OF FLUDARABINE PHOSPHATE IN LYMPHOMA - AN EFFECTIVE NEW AGENT IN LOW-GRADE LYMPHOMA [J].

REDMAN, JR ;

CABANILLAS, F ;

VELASQUEZ, WS ;

MCLAUGHLIN, P ;

HAGEMEISTER, FB ;

SWAN, F ;

RODRIGUEZ, MA ;

PLUNKETT, WK ;

KEATING, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) :790-794

← 1 →